595 related articles for article (PubMed ID: 19476995)
21. [Neurofibromatosis type 2 (NF2)--classical example of a rare familial cancer syndrome].
Wiszniewski W
Med Wieku Rozwoj; 1999; 3(1):47-54. PubMed ID: 10910638
[TBL] [Abstract][Full Text] [Related]
22. DNA diagnosis of neurofibromatosis 2. Altered coding sequence of the merlin tumor suppressor in an extended pedigree.
MacCollin M; Mohney T; Trofatter J; Wertelecki W; Ramesh V; Gusella J
JAMA; 1993 Nov; 270(19):2316-20. PubMed ID: 8230593
[TBL] [Abstract][Full Text] [Related]
23. Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II].
Evans DG
Genet Med; 2009 Sep; 11(9):599-610. PubMed ID: 19652604
[TBL] [Abstract][Full Text] [Related]
24. Current progress in genomics and targeted therapies for neurofibromatosis type 2.
Hiruta R; Saito K; Bakhit M; Fujii M
Fukushima J Med Sci; 2023 Aug; 69(2):95-103. PubMed ID: 37468280
[TBL] [Abstract][Full Text] [Related]
25. [Neurofibromatosis type 2 as a result of a de novo mutation: a case report].
Noguera-Julian A; Perez-Dueñas B; Pons M; Cambra-Lasaosa FJ; Palomeque-Rico A; Fortuny C; García-Cazorla A; Campistol J
Rev Neurol; 2002 Dec 1-15; 35(11):1030-3. PubMed ID: 12497309
[TBL] [Abstract][Full Text] [Related]
26. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
[TBL] [Abstract][Full Text] [Related]
27. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
[TBL] [Abstract][Full Text] [Related]
28. NF2: the wizardry of merlin.
Xiao GH; Chernoff J; Testa JR
Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
[TBL] [Abstract][Full Text] [Related]
29. Novel neurofibromatosis type 2 mutation presenting with status epilepticus.
DiFrancesco JC; Sestini R; Cossu F; Bolognesi M; Sala E; Mariani S; Saracchi E; Papi L; Ferrarese C
Epileptic Disord; 2014 Mar; 16(1):132-7. PubMed ID: 24667735
[TBL] [Abstract][Full Text] [Related]
30. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
31. Correlation of nonsense and frameshift mutations with severity of retinal abnormalities in neurofibromatosis 2.
Feucht M; Kluwe L; Mautner VF; Richard G
Arch Ophthalmol; 2008 Oct; 126(10):1376-80. PubMed ID: 18852415
[TBL] [Abstract][Full Text] [Related]
32. The parental origin of new mutations in neurofibromatosis 2.
Kluwe L; Mautner V; Parry DM; Jacoby LB; Baser M; Gusella J; Davis K; Stavrou D; MacCollin M
Neurogenetics; 2000 Sep; 3(1):17-24. PubMed ID: 11085592
[TBL] [Abstract][Full Text] [Related]
33. Molecular Analysis of a Patient With Neurofibromatosis 2 (NF2) and Peritoneal Malignant Mesothelioma.
Glass C; Sholl LM; Landgraf JR; Chirieac L; Roggli VL
Am J Surg Pathol; 2020 Feb; 44(2):288-292. PubMed ID: 31567203
[TBL] [Abstract][Full Text] [Related]
34. Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors.
Kluwe L; Friedrich RE; Hagel C; Lindenau M; Mautner VF
J Invest Dermatol; 2000 May; 114(5):1017-21. PubMed ID: 10771486
[TBL] [Abstract][Full Text] [Related]
35. Advances in neurofibromatosis 2 (NF2): a workshop report.
Lim DJ; Rubenstein AE; Evans DG; Jacks T; Seizinger BG; Baser ME; Beebe D; Brackmann DE; Chiocca EA; Fehon RG; Giovannini M; Glazer R; Gusella JF; Gutmann DH; Korf B; Lieberman F; Martuza R; McClatchey AI; Parry DM; Pulst SM; Ramesh V; Ramsey WJ; Ratner N; Rutkowski JL; Ruttledge M; Weinstein DE
J Neurogenet; 2000 Jun; 14(2):63-106. PubMed ID: 10992163
[No Abstract] [Full Text] [Related]
36. Loss of heterozygosity for the NF2 gene in retinal and optic nerve lesions of patients with neurofibromatosis 2.
Chan CC; Koch CA; Kaiser-Kupfer MI; Parry DM; Gutmann DH; Zhuang Z; Vortmeyer AO
J Pathol; 2002 Sep; 198(1):14-20. PubMed ID: 12210058
[TBL] [Abstract][Full Text] [Related]
37. Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors.
Louis DN; Ramesh V; Gusella JF
Brain Pathol; 1995 Apr; 5(2):163-72. PubMed ID: 7670657
[TBL] [Abstract][Full Text] [Related]
38. Allelic expression of the NF2 gene in neurofibromatosis 2 and schwannomatosis.
Jacoby LB; MacCollin M; Parry DM; Kluwe L; Lynch J; Jones D; Gusella JF
Neurogenetics; 1999 Apr; 2(2):101-8. PubMed ID: 10369886
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas.
Rubio MP; Correa KM; Ramesh V; MacCollin MM; Jacoby LB; von Deimling A; Gusella JF; Louis DN
Cancer Res; 1994 Jan; 54(1):45-7. PubMed ID: 8261460
[TBL] [Abstract][Full Text] [Related]
40. Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas.
Mérel P; Hoang-Xuan K; Sanson M; Moreau-Aubry A; Bijlsma EK; Lazaro C; Moisan JP; Resche F; Nishisho I; Estivill X
Genes Chromosomes Cancer; 1995 Jul; 13(3):211-6. PubMed ID: 7669741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
